Transradial Access Devices Market

What are key Factors Propelling the Surge of Global
Transradial Access Devices Market?
© P&S Intelligence. All rights reserved Page 1

The preference for radial artery access for interventional operations is steadily rising around the world.
The numerous advantages of this approach in transarterial chemoembolization, in cancer treatment, are
fuelling the surge in the preference for transradial access devices. Moreover, the suitability of the
procedure for a wide range of patients, such as morbidly obese patients, those suffering from severe
peripheral vascular diseases, elderly (especially women), and those on oral anticoagulation medicines,
and thus, at an extremely high risk of vascular access site bleeding, makes these devices highly soughtafter.
Moreover, the lower cost and favorable clinical outcomes of the transradial access procedure, as
compared to the transfemoral approach, is expected to reduce healthcare expenses, especially in the
emerging economies. Therefore, the global transradial access devices market is expected to witness an
increase in its valuation from $14.9 billion in 2017 to $24.1 billion by 2023, at a CAGR of 8.4% during the
forecast period (2018–2023). Transradial access simply means to snake a catheter or tube into the body
via the radial artery, which runs through the forearm.
Receive Sample Copy of this Report:https://www.psmarketresearch.com/marketanalysis/transradial-access-devices-market/report-sample
These devices are used in various procedures in the healthcare industry, such as drug administration,
blood transfusion, diagnostics and testing, and fluid and nutrition administration. Amongst these, the
demand for these devices was the highest for the drug administration application in 2017, mainly due to
the wide-scale utilization of vascular-access devices for medication and treatment of cancer and several
infections. As per the World Health Organization, 18.1 million people were diagnosed with the disease in
2018, and 9.6 million succumbed to it that year.
Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiryurl=transradial-access-devices-market
The transradial access devices market is currently witnessing the rising number of collaborations of
manufacturing companies with medical device preprocessing firms, shifting focus toward the
development of robotic-assisted catheter systems, and increasing activities of the prominent companies
in developing countries. In addition to this, the major companies are also launching innovative products
in order to better serve customers and the medical cause. For instance, Teleflex Incorporated received
the 510(k) clearance from the United States Food and Drug Administration (USFDA) in 2017 for its
Spectre Guidewire and Twin-Pass Torque Dual Access Catheter.
Therefore, it can be concluded that the demand for transradial access devices is set to skyrocket in the
coming years, owing to the numerous advantages offered by them over snaking a catheter or tubing
through the femoral vein in the thigh.
© P&S Intelligence. All rights reserved Page 2

Disclaimer:
P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities.
P&S Intelligence ensures the reliability and accuracy of information and data provided in its market
research publications. However, the information in publications is subject to fluctuations, as it is based
on primary interviews of officials from various companies or organizations. P&S Intelligence is not
responsible for any incorrect data provided by the key industry players of the concerned domain. The
information or analysis in P&S Intelligence publications represents opinions based on research and
should not be interpreted as statements of fact. Information in this report was believed to be correct
at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any
product, service, or vendor depicted in its research publications.
All intellectual properties, including trademarks and copyrights, belong to their respective owners and
may be protected by copyright. Under no circumstance can these be reproduced in any form
without prior written agreement of their owners.
An order for market research report is intended for internal use of the company only and not for
disclosure to third parties or any other publication in general. No service, report, or part thereof
provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed,
circulated, or sublicensed in any medium or form now realized or hereafter become realized,
including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without
a written permission from Prescient & Strategic Intelligence Pvt. Ltd.
Kindly write to: enquiry@psmarketresearch.com
B-13, Sector – 2, Noida, U.P. – 201301, INDIA
Contact No: +91 120 4541 337
US/Canada Toll-Free: 1-888-778-7886
© P&S Intelligence. All rights reserved
© P&S Intelligence. All rights reserved Page 3